ICS/LABA

DRUG3 trials

Sponsors

The First Affiliated Hospital of Guangzhou Medical University, Second Affiliated Hospital, School of Medicine, Zhejiang University, Regeneron Pharmaceuticals

Conditions

AsthmaAzithromycinChest SyndromeEffect of Drug

Phase 4

Effects of Leukotriene Modulator Montelukast on Cough Variant Asthma

The First Affiliated Hospital of Guangzhou Medical UniversityAsthma

Start: 2012-02-29End: 2014-08-31Target: 99Updated: 2014-07-14

Azithromycin Treatment for Non-eosinophilic Chest Tightness Variant Asthma

Second Affiliated Hospital, School of Medicine, Zhejiang UniversityAsthma, Azithromycin, Chest Syndrome +1

Start: 2023-01-01End: 2024-03-31Target: 248Updated: 2022-11-04

Efficacy of Dupilumab Added to Medium Dose Inhaled Corticosteroid/Long-acting Beta-agonist (ICS/LABA) in Comparison to ICS Dose Escalation to High Dose ICS/LABA in Adolescent and Adult Patients With Uncontrolled Asthma

Active, not recruitingNCT06572228

Regeneron PharmaceuticalsAsthma

Start: 2024-08-26End: 2027-04-24Updated: 2026-05-22

Related Papers

Effects of treatment with montelukast alone, budesonide/formoterol alone and a combination of both in cough variant asthma

Respiratory Research2022-10-1029 citations